Masataka Umeda

2.3k total citations
91 papers, 1.2k citations indexed

About

Masataka Umeda is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Masataka Umeda has authored 91 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 34 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in Masataka Umeda's work include Systemic Lupus Erythematosus Research (17 papers), Inflammasome and immune disorders (12 papers) and Vasculitis and related conditions (12 papers). Masataka Umeda is often cited by papers focused on Systemic Lupus Erythematosus Research (17 papers), Inflammasome and immune disorders (12 papers) and Vasculitis and related conditions (12 papers). Masataka Umeda collaborates with scholars based in Japan, United States and Switzerland. Masataka Umeda's co-authors include Atsushi Kawakami, Hideki Nakamura, Kunihiro Ichinose, Tomohiro Koga, Tomoki Origuchi, Naoki Iwamoto, Shin‐ya Kawashiri, Mami Tamai, Shoichi Fukui and Toshimasa Shimizu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Masataka Umeda

84 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Umeda Japan 20 517 474 351 159 145 91 1.2k
M. Galeazzi Italy 22 344 0.7× 551 1.2× 284 0.8× 98 0.6× 157 1.1× 66 1.2k
Gráinne Murphy Ireland 15 598 1.2× 771 1.6× 254 0.7× 113 0.7× 91 0.6× 38 1.4k
Taiichiro Miyashita Japan 18 299 0.6× 310 0.7× 277 0.8× 86 0.5× 73 0.5× 50 845
J. M. Heward United Kingdom 27 1.0k 2.0× 269 0.6× 412 1.2× 132 0.8× 74 0.5× 39 2.6k
Monika Hermansson United Kingdom 15 253 0.5× 933 2.0× 437 1.2× 152 1.0× 94 0.6× 19 1.6k
Hsien‐Tzung Liao Taiwan 20 417 0.8× 720 1.5× 263 0.7× 51 0.3× 190 1.3× 80 1.1k
Yuichiro Fujieda Japan 22 403 0.8× 892 1.9× 231 0.7× 194 1.2× 331 2.3× 93 1.6k
Taku Yoshio Japan 25 774 1.5× 1.1k 2.3× 326 0.9× 173 1.1× 108 0.7× 70 2.0k
P. Martin van Hagen Netherlands 21 457 0.9× 267 0.6× 210 0.6× 217 1.4× 70 0.5× 62 1.2k
Eri Katsuyama Japan 20 367 0.7× 276 0.6× 430 1.2× 69 0.4× 49 0.3× 53 1.2k

Countries citing papers authored by Masataka Umeda

Since Specialization
Citations

This map shows the geographic impact of Masataka Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Umeda more than expected).

Fields of papers citing papers by Masataka Umeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Umeda. The network helps show where Masataka Umeda may publish in the future.

Co-authorship network of co-authors of Masataka Umeda

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Umeda. A scholar is included among the top collaborators of Masataka Umeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Umeda. Masataka Umeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karino, Kohei, Masataka Umeda, Wenliang Pan, et al.. (2025). ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling. Arthritis & Rheumatology. 77(12). 1689–1696.
3.
Umeda, Masataka, Naoki Iwamoto, Ritsuko Miyashita, et al.. (2024). Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients. Frontiers in Immunology. 15. 1501146–1501146. 3 indexed citations
4.
Kawano, Hiroaki, et al.. (2023). Chest pain and Raynaud’s phenomenon after COVID-19 vaccination in a patient previously diagnosed with systemic lupus erythematosus: a case report. European Heart Journal - Case Reports. 7(3). ytad102–ytad102. 2 indexed citations
5.
Shimizu, Toshimasa, Masataka Umeda, Kaori Furukawa, et al.. (2023). The Toll-like Receptor 7-Mediated Ro52 Antigen-Presenting Pathway in the Salivary Gland Epithelial Cells of Sjögren’s Syndrome. Journal of Clinical Medicine. 12(13). 4423–4423. 8 indexed citations
6.
Scherlinger, Marc, Wenliang Pan, Ryo Hisada, et al.. (2022). Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Science Advances. 8(48). eadc9657–eadc9657. 34 indexed citations
7.
Origuchi, Tomoki, Masataka Umeda, Tomohiro Koga, et al.. (2022). Comparison of complications during 1-year follow-up between remitting seronegative symmetrical synovitis with pitting edema syndrome and elderly-onset rheumatoid arthritis. Immunological Medicine. 45(3). 168–174. 3 indexed citations
8.
Hisada, Ryo, Nobuya Yoshida, Masataka Umeda, et al.. (2022). Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 74(7). 1204–1210. 12 indexed citations
9.
Hisada, Ryo, Nobuya Yoshida, Masataka Umeda, et al.. (2022). The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription. Cellular and Molecular Immunology. 19(6). 738–750. 22 indexed citations
10.
Umeda, Masataka, Nobuya Yoshida, Ryo Hisada, et al.. (2021). ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1. Proceedings of the National Academy of Sciences. 118(18). 15 indexed citations
11.
Matsumoto, Haruki, Yuya Fujita, Naoki Matsuoka, et al.. (2021). Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD). Arthritis Research & Therapy. 23(1). 148–148. 9 indexed citations
12.
Nakane, Shunya, Masataka Umeda, Shin‐ya Kawashiri, et al.. (2020). Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies. Arthritis Research & Therapy. 22(1). 32–32. 15 indexed citations
13.
Kawashiri, Shin‐ya, Keita Fujikawa, Ayako Nishino, et al.. (2019). Combination of ultrasound power Doppler‐verified synovitis and seropositivity accurately identifies patients with early‐stage rheumatoid arthritis. International Journal of Rheumatic Diseases. 22(5). 842–851. 5 indexed citations
14.
Kawashiri, Shin‐ya, Tomoki Origuchi, Masataka Umeda, et al.. (2018). Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease. Arthritis Research & Therapy. 20(1). 277–277. 14 indexed citations
15.
Ichinose, Kunihiro, Mineaki Kitamura, Shuntaro Sato, et al.. (2018). Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis. Clinical Immunology. 197. 161–168. 17 indexed citations
16.
Fukui, Shoichi, Naoki Iwamoto, Ayuko Takatani, et al.. (2018). M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis. Frontiers in Immunology. 8. 1958–1958. 166 indexed citations
17.
Iwamoto, Naoki, Ayuko Takatani, Toshimasa Shimizu, et al.. (2017). Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis. PLoS ONE. 12(5). e0177057–e0177057. 23 indexed citations
18.
Koga, Tomohiro, Kiyoshi Migita, Shuntaro Sato, et al.. (2016). Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever. Medicine. 95(16). e3449–e3449. 46 indexed citations
19.
Fukui, Shoichi, Naoki Iwamoto, Toshimasa Shimizu, et al.. (2016). Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years. Arthritis Research & Therapy. 18(1). 293–293. 10 indexed citations
20.
Fukui, Shoichi, Naoki Iwamoto, Masataka Umeda, et al.. (2015). Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy. Medicine. 94(45). e1943–e1943. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026